1 completed, 1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Metabolic: new trials by email Literature Review of Metabolic trials Research Report on Metabolic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. combination chemotherapy with Apatinib or Camrelizumab - Advanced Gastric Cancer, Neoadjuvant Therapy | Completed | Fujian Medical University | 234 | 2022-06-01 | 2024-04-19 | |
| Assessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CA Monalizumab, Oxaliplatin, 5-Fluorouracil - Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction | Phase 1 / Phase 2 | Withdrawn | Jules Bordet Institute | 2017-07-20 | 2017-12-19 |
Adenocarcinoma Of Esophagus (1) · Esophageal Squamous Cell Carcinoma (1)
Fujian Medical University (1) · Jules Bordet Institute (1)
Belgium (1) · China (1)
Amelie Deleporte, Physician (1)
2016 (1)